COVID-19 Infection in Patients Receiving Anti-CD20 Therapy

Clinical trial NCT04884477 · COMPLETED

Trial details

NCT number: NCT04884477
Sponsor: Mayo Clinic
Status: COMPLETED
Study type: OBSERVATIONAL

COVID-19 Immunosuppressed Host Convalescent Plasma Anti-CD20 Therapy

Start date: 2021-06-01
Primary completion: 2023-01-15
Enrollment: 342

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.